Assessment Of The Impact Of Anti-Drug Antibodies On Pk And Clinical Outcomes With Atezolizumab Plus Bevacizumab In Hcc.Peter R. Galle,Richard S. Finn,Ann-Lii Cheng,Coen Bernaards,Colby S. Shemesh,Alexandr Vilimovskij,Wendy J. Verret,Sven F. Stanzel,Ning Ma,Michel Ducreux,Andrew X. ZhuCANCER RESEARCH(2021)引用 4|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要